{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:11:24Z","timestamp":1794265884552,"version":"4.9.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bisphosphonates (BPs) are widely used to treat bone disorders, prevent skeletal-related events, and manage bone metastasis. These drugs are synthetic analogs of pyrophosphate and primarily function by inhibiting osteoclast activity. However, increasing evidence suggests that they also have an effect on osteoblasts. This systematic review aims to evaluate how bisphosphonates affect osteoblasts by summarizing findings from in vitro studies on the impact of BPs on osteoblast lineage cells, addressing the following question: \u201c\n                    <jats:italic>Do bisphosphonates affect osteoblast cell lineage function?<\/jats:italic>\n                    \u201d. For this purpose, the PICO framework was followed, and 36 articles were selected for inclusion in this review. The data suggest that the molecular mechanisms in osteoblasts can vary depending on the specific type of bisphosphonate, as well as the concentration and duration of treatment, leading to either stimulation or inhibition of osteogenesis. Additionally, studies have shown that certain BPs, such as zoledronic acid, can interfere with osteoblast differentiation, proliferation, gene expression, and mineralization capacity, potentially impairing bone healing. On the other hand, other drugs, such as alendronate, demonstrate more positive effects on cell function. Some drugs, such as pamidronate and clodronate, exhibited mixed effects; however, it was observed that high concentrations of these drugs can lead to cytotoxic effects. Despite these adverse effects, it is important to recognize that the clinical benefits of managing bone disorders often outweigh the potential risks highlighted in this review.\n                  <\/jats:p>","DOI":"10.1007\/s00223-025-01390-w","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T13:16:34Z","timestamp":1750079794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Systematic Review of the Effects of Bisphosphonates on Osteoblasts In Vitro"],"prefix":"10.1007","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6446-3643","authenticated-orcid":false,"given":"Henrique","family":"Hadad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00eds Kawamata","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00edsa Pereira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Eduarda de Freitas Santana","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Pozzi Semeghini","family":"Guastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisley \u00c1vila","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"1390_CR1","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0089","author":"UT Iwaniec","year":"2016","unstructured":"Iwaniec UT, Turner RT (2016) Influence of body weight on bone mass, architecture and turnover. J Endocrinol. https:\/\/doi.org\/10.1530\/JOE-16-0089","journal-title":"J Endocrinol"},{"key":"1390_CR2","doi-asserted-by":"publisher","DOI":"10.1115\/1.4029176","author":"R Oftadeh","year":"2015","unstructured":"Oftadeh R, Perez-Viloria M, Villa-Camacho JC, Vaziri A, Nazarian A (2015) Biomechanics and mechanobiology of trabecular bone: a review. J Biomech Eng. https:\/\/doi.org\/10.1115\/1.4029176","journal-title":"J Biomech Eng"},{"key":"1390_CR3","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.9.1583","author":"AM Parfitt","year":"2001","unstructured":"Parfitt AM (2001) The bone remodeling compartment: a circulatory function for bone lining cells. J Bone Miner Res. https:\/\/doi.org\/10.1359\/jbmr.2001.16.9.1583","journal-title":"J Bone Miner Res"},{"key":"1390_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra053077","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD (2006) Bone quality \u2013 the material and structural basis of bone strength and fragility. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMra053077","journal-title":"N Engl J Med"},{"key":"1390_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6910312","author":"M Tobeiha","year":"2020","unstructured":"Tobeiha M, Moghadasian MH, Amin N, Jafarnejad S (2020) RANKL\/RANK\/OPG Pathway: a mechanism involved in exercise-induced bone remodeling. Biomed Res Int. https:\/\/doi.org\/10.1155\/2020\/6910312","journal-title":"Biomed Res Int"},{"key":"1390_CR6","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.20.3.0367","author":"T Suda","year":"1999","unstructured":"Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endroc Ver. https:\/\/doi.org\/10.1210\/edrv.20.3.0367","journal-title":"Endroc Ver"},{"key":"1390_CR7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.8.4254","author":"T Kaneda","year":"2000","unstructured":"Kaneda T, Nojima T, Nakagawa M, Ogasawara A, Kaneko H, Sato T, Mano H, Kumegawa M, Hakeda Y (2000) Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-Kappa B ligand and macrophage-colonystimulating factor. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.165.8.4254","journal-title":"J Immunol"},{"key":"1390_CR8","doi-asserted-by":"publisher","DOI":"10.1124\/mi.10.3.5","author":"MT Drake","year":"2010","unstructured":"Drake MT, Cremers SC (2010) Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition. Mol Interv. https:\/\/doi.org\/10.1124\/mi.10.3.5","journal-title":"Mol Interv"},{"key":"1390_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172773","author":"A Ku\u017anik","year":"2020","unstructured":"Ku\u017anik A, Pa\u017adzierniok-Holewa A, Jewula P, Ku\u017anik N (2020) Bisphosphonates-much more than only drugs for bone diseases. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172773","journal-title":"Eur J Pharmacol"},{"key":"1390_CR10","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2007-0245","author":"M Aapro","year":"2010","unstructured":"Aapro M, Saad F, Costa L (2010) Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases. Oncologist. https:\/\/doi.org\/10.1634\/theoncologist.2007-0245","journal-title":"Oncologist"},{"key":"1390_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.6745","author":"WJ Deardorff","year":"2022","unstructured":"Deardorff WJ, Cenzer I, Nguyen B, Lee SJ (2022) Time to benefit of bisphosphonate therapy for the prevention of fractures among postmenopausal women with osteoporosis: a meta-analysis of randomized clinical trials. JAMA Intern Med. https:\/\/doi.org\/10.1001\/jamainternmed.2021.6745","journal-title":"JAMA Intern Med"},{"key":"1390_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.356","author":"MA Perazella","year":"2008","unstructured":"Perazella MA, Markowitz GS (2008) Bisphosphonate nephrotoxicity. Kidney Int. https:\/\/doi.org\/10.1038\/ki.2008.356","journal-title":"Kidney Int"},{"key":"1390_CR13","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.12149","author":"A So","year":"2012","unstructured":"So A, Chin J, Fleshner N, Saad F (2012) Management of skeletal-related events in patients with advanced prostate cancer and bone metastases: incorporating new agents into clinical practice. Can Urol Assoc J. https:\/\/doi.org\/10.5489\/cuaj.12149","journal-title":"Can Urol Assoc J"},{"key":"1390_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.02.008","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D (2022) American association of oral and maxillofacial surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"1390_CR15","doi-asserted-by":"publisher","first-page":"115493","DOI":"10.1016\/j.bone.2020.115493","volume":"139","author":"MJ Rogers","year":"2020","unstructured":"Rogers MJ, M\u00f6nkk\u00f6nen J, Munoz MA (2020) Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton. Bone 139:115493. https:\/\/doi.org\/10.1016\/j.bone.2020.115493","journal-title":"Bone"},{"key":"1390_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq516","author":"M Pazianas","year":"2011","unstructured":"Pazianas M (2011) Osteonecrosis of the jaw and the role of macrophages. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/djq516","journal-title":"J Natl Cancer Inst"},{"key":"1390_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.12.225","author":"FP Coxon","year":"2008","unstructured":"Coxon FP, Thompson K, Roelofs AJ, Ebetino FH, Rogers MJ (2008) Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells. Bone. https:\/\/doi.org\/10.1016\/j.bone.2007.12.225","journal-title":"Bone"},{"key":"1390_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.165.3899.1264","author":"MD Francis","year":"1969","unstructured":"Francis MD, Russell RGG, Fleisch H (1969) Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science. https:\/\/doi.org\/10.1126\/science.165.3899.1264","journal-title":"Science"},{"key":"1390_CR19","unstructured":"Benedict JJ (1982) The physical chemistry of the diphosphonates\u2014 its relationship to their medical activity. In: Donath A, Courvoiser B (eds) Symposium CEMO (Centre d\u2019Etude des Maladies Ost\u00e9oarticulaires de Gen\u00e8ve) IV. Diphosphonates and bone. Editions M\u00e9decine at Hygi\u00e8ne, Geneva, pp 1\u201319."},{"key":"1390_CR20","first-page":"125","volume-title":"Bisphosphonate on bones","author":"A Ebrahimpour","year":"1995","unstructured":"Ebrahimpour A, Francis MD (1995) Bisphosphonate therapy in acute and chronic bone loss: physical chemical considerations in bisphosphonate-related therapies. In: Bijvoet OLM, Fleisch HA, Canfield RE, Russell RGG (eds) Bisphosphonate on bones. Elsevier, Amsterdam, pp 125\u2013136"},{"key":"1390_CR21","volume-title":"Bisphosphonate on bones","year":"1995","unstructured":"Bijvoet OLM, Fleisch HA, Canfield RE, Russell RGG (eds) (1995) Bisphosphonate on bones. Elsevier, Amsterdam"},{"key":"1390_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0540-8","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. https:\/\/doi.org\/10.1007\/s00198-007-0540-8","journal-title":"Osteoporos Int"},{"key":"1390_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1216-7","author":"N Maruotti","year":"2012","unstructured":"Maruotti N, Corrado A, Neve A, Cantatore FP (2012) Bisphosphonates: effects on osteoblast. Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-012-1216-7","journal-title":"Eur J Clin Pharmacol"},{"key":"1390_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.115850","volume":"145","author":"PR Jensen","year":"2021","unstructured":"Jensen PR, Andersen TL, Chavassieux P, Roux JP, Delaisse JM (2021) Bisphosphonates impair the onset of bone formation at remodeling sites. Bone 145:115850. https:\/\/doi.org\/10.1016\/j.bone.2021.115850","journal-title":"Bone"},{"key":"1390_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2023.101479","author":"H Hadad","year":"2023","unstructured":"Hadad H, Matheus HR, Chen JE, Jounaidi Y, Souza F\u00c1, Guastaldi FP (2023) Dose-dependent effects of zoledronic acid on the osteogenic differentiation of human bone marrow stem cells (hBMSCs). J Stomatol Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.jormas.2023.101479","journal-title":"J Stomatol Oral Maxillofac Surg"},{"issue":"6","key":"1390_CR26","first-page":"873","volume":"28","author":"A Corrado","year":"2010","unstructured":"Corrado A, Neve A, Maruotti N, Gaudio A, Marucci A, Cantatore FP (2010) Dose-dependent metabolic effect of zoledronate on primary human osteoblastic cell cultures. Clin Exp Rheumatol 28(6):873\u2013876","journal-title":"Clin Exp Rheumatol"},{"key":"1390_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2010.01720.x","author":"C Walter","year":"2011","unstructured":"Walter C, Pabst A, Ziebart T, Klein MO, Al-Nawas B (2011) Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis. https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01720.x","journal-title":"Oral Dis"},{"key":"1390_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2016.05.030","author":"M Lang","year":"2016","unstructured":"Lang M, Zhou Z, Shi L, Niu J, Xu S, Lin W, Chen Z, Wang Y (2016) Influence of zoledronic acid on proliferation, migration, and apoptosis of vascular endothelial cells. Br J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.bjoms.2016.05.030","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1390_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179248","author":"SY Gao","year":"2017","unstructured":"Gao SY, Zheng GS, Wang L, Liang YJ, Zhang SE, Lao XM, Li K, Liao GQ (2017) Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0179248","journal-title":"PLoS One"},{"key":"1390_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.01.007","author":"MR Allen","year":"2009","unstructured":"Allen MR, Burr DB (2009) The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2009.01.007","journal-title":"J Oral Maxillofac Surg"},{"key":"1390_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.11.020","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. https:\/\/doi.org\/10.1016\/j.bone.2010.11.020","journal-title":"Bone"},{"key":"1390_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720948497","author":"E Anna Di Vito","year":"2020","unstructured":"Anna Di Vito E, Chiarella F, Baudi P, Scardamaglia A, Antonelli D, Giudice T, Barni L, Fortunato A. Giudice (2020) Dose-dependent effects of zoledronic acid on human periodontal ligament stem cells: an in vitro pilot study. Cell Trans. https:\/\/doi.org\/10.1177\/0963689720948497","journal-title":"Cell Trans"},{"key":"1390_CR33","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4627","author":"X Huang","year":"2016","unstructured":"Huang X, Huang S, Guo F, Xu F, Cheng P, Ye Y, Dong Y, Xiang W, Chen A (2016) Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2015.4627","journal-title":"Mol Med Rep"},{"issue":"1","key":"1390_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00223-021-00890-9","volume":"110","author":"R Kozutsumi","year":"2022","unstructured":"Kozutsumi R, Kuroshima S, Kaneko H, Sasaki M, Ishisaki A, Sawase T (2022) Zoledronic acid deteriorates soft and hard tissue healing of murine tooth extraction sockets in a dose-dependent manner. Calcif Tissue Int 110(1):104\u2013116. https:\/\/doi.org\/10.1007\/s00223-021-00890-9","journal-title":"Calcif Tissue Int"},{"key":"1390_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bone.2019.03.027","volume":"123","author":"A Hokugo","year":"2019","unstructured":"Hokugo A, Kanayama K, Sun S, Morinaga K, Sun Y, Wu Q, Sasaki H, Okawa H, Evans C, Ebetino FH, Lundy MW, Sadrerafi K, McKenna CE, Nishimura I (2019) Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice. Bone 123:115\u2013128. https:\/\/doi.org\/10.1016\/j.bone.2019.03.027","journal-title":"Bone"},{"key":"1390_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"1390_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/S1532-3382(01)70024-3","author":"SA Miller","year":"2001","unstructured":"Miller SA, Forrest JL (2001) Enhancing your practice through evidence-based decision making: PICO, learning how to ask good questions. J Evid Based Dent Pract. https:\/\/doi.org\/10.1016\/S1532-3382(01)70024-3","journal-title":"J Evid Based Dent Pract"},{"key":"1390_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-021-01295-w","author":"L Tran","year":"2021","unstructured":"Tran L, Tam DNH, Elshafay A, Dang T, Hirayama K, Huy NT (2021) Quality assessment tools used in systematic reviews of in vitro studies: a systematic review. BMC Med Res Methodol. https:\/\/doi.org\/10.1186\/s12874-021-01295-w","journal-title":"BMC Med Res Methodol"},{"key":"1390_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto_176.x","author":"M Kellinsalmi","year":"2005","unstructured":"Kellinsalmi M, Monkkonen H, Monkkonen J, Leskela HV, Parikka V, Hamalainen M, Lehenkari P (2005) In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts. Basic Clin Pharmacol Toxicol. https:\/\/doi.org\/10.1111\/j.1742-7843.2005.pto_176.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1390_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21983","author":"IR Orriss","year":"2009","unstructured":"Orriss IR, Key ML, Colston KW, Arnett TR (2009) Inhibition of osteoblast function in vitro by aminobisphosphonates. J Cell Biochem. https:\/\/doi.org\/10.1002\/jcb.21983","journal-title":"J Cell Biochem"},{"key":"1390_CR41","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1616","author":"A Labrinidis","year":"2009","unstructured":"Labrinidis A, Hay S, Liapis V, Ponomarev V, Findlay DM, Evdokiou A (2009) Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1616","journal-title":"Clin Cancer Res"},{"key":"1390_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1746-160X-7-4","author":"FP Koch","year":"2011","unstructured":"Koch FP, Wunsch A, Merkel C, Ziebart T, Pabst A, Yekta SS, Blessmann M, Smeets R (2011) The influence of bisphosphonates on human osteoblast migration and integrin aVb3\/tenascin C gene expression in vitro. Head Face Med. https:\/\/doi.org\/10.1186\/1746-160X-7-4","journal-title":"Head Face Med"},{"key":"1390_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-014-1280-8","author":"S Zara","year":"2015","unstructured":"Zara S, De Colli M, Di Giacomo V, Zizzari VL, Di Nisio C, Di Tore U, Salini V, Gallorini M, Tet\u00e8 S, Cataldi A (2015) Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts. Clin Oral Investig. https:\/\/doi.org\/10.1007\/s00784-014-1280-8","journal-title":"Clin Oral Investig"},{"key":"1390_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-015-1706-y","author":"S Zafar","year":"2016","unstructured":"Zafar S, Coates DE, Cullinan MP, Drummond BK, Milne T, Seymour GJ (2016) Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts. Clin Oral Investig. https:\/\/doi.org\/10.1007\/s00784-015-1706-y","journal-title":"Clin Oral Investig"},{"key":"1390_CR45","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.32612","author":"KC Huang","year":"2019","unstructured":"Huang KC, Huang TW, Chuang PY, Yang TY, Chang SF (2019) Zoledronate induces cell cycle arrest and differentiation by upregulating p21 in mouse MC3T3-E1 preosteoblasts. Int J Med Sci. https:\/\/doi.org\/10.7150\/ijms.32612","journal-title":"Int J Med Sci"},{"key":"1390_CR46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0426","author":"S Pozzi","year":"2009","unstructured":"Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N (2009) High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0426","journal-title":"Clin Cancer Res"},{"key":"1390_CR47","doi-asserted-by":"publisher","DOI":"10.1159\/000351194","author":"FG Basso","year":"2013","unstructured":"Basso FG, Turrioni AP, Hebling J, de Souza Costa CA (2013) Zoledronic acid inhibits human osteoblast activities. Gerontology. https:\/\/doi.org\/10.1159\/000351194","journal-title":"Gerontology"},{"key":"1390_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-017-1187-8","author":"T Yaz\u0131c\u0131","year":"2018","unstructured":"Yaz\u0131c\u0131 T, Ko\u00e7er G, Naz\u0131ro\u011flu M, \u00d6vey \u0130S, \u00d6z A (2018) Zoledronic acid, bevacizumab and dexamethasone-induced apoptosis, mitochondrial oxidative stress, and calcium signaling are decreased in human osteoblast-like cell line by selenium treatment. Biol Trace Elem Rese. https:\/\/doi.org\/10.1007\/s12011-017-1187-8","journal-title":"Biol Trace Elem Rese"},{"key":"1390_CR49","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2004.19.1.147","author":"B Pan","year":"2004","unstructured":"Pan B, Farrugia AN, To LB, Findlay DM, Green J, Lynch K, Zannettino AC (2004) The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-\u03b1 converting enzyme (TACE). J Bone Min Res. https:\/\/doi.org\/10.1359\/jbmr.2004.19.1.147","journal-title":"J Bone Min Res"},{"key":"1390_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.30950","author":"S Greiner","year":"2006","unstructured":"Greiner S, Kadow-Romacker A, L\u00fcbberstedt M, Schmidmaier G, Wildemann B (2006) The effect of zoledronic acid incorporated in a poly(D, L-lactide) implant coating on osteoblasts in vitro. J Biomed Mater Res A. https:\/\/doi.org\/10.1002\/jbm.a.30950","journal-title":"J Biomed Mater Res A"},{"key":"1390_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2012.01154.x","author":"S Patntirapong","year":"2012","unstructured":"Patntirapong S, Singhatanadgit W, Chanruangvanit C, Lavanrattanakul K, Satravaha Y (2012) Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition. J Oral Pathol Med. https:\/\/doi.org\/10.1111\/j.1600-0714.2012.01154.x","journal-title":"J Oral Pathol Med"},{"key":"1390_CR52","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.22627","author":"FJ Manzano-Moreno","year":"2018","unstructured":"Manzano-Moreno FJ, Ramos-Torrecillas J, Melguizo-Rodr\u00edguez L, Illescas-Montes R, Ruiz C, Garc\u00eda-Mart\u00ednez O (2018) Bisphosphonate modulation of the gene expression of different markers involved in osteoblast physiology: possible implications in bisphosphonate-related osteonecrosis of the jaw. Int J Med Sci. https:\/\/doi.org\/10.7150\/ijms.22627","journal-title":"Int J Med Sci"},{"key":"1390_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081803","author":"JM Kim","year":"2019","unstructured":"Kim JM, Yang YS, Park KH, Oh H, Greenblatt MB, Shim JH (2019) The ERK MAPK pathway is essential for skeletal development and homeostasis. Int J Med Sci. https:\/\/doi.org\/10.3390\/ijms20081803","journal-title":"Int J Med Sci"},{"key":"1390_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/1746-160X-6-12","author":"FP Koch","year":"2010","unstructured":"Koch FP, Yekta SS, Merkel C, Ziebart T, Smeets R (2010) The impact of bisphosphonates on the osteoblast proliferation and collagen gene expression in vitro. Head Face Med. https:\/\/doi.org\/10.1186\/1746-160X-6-12","journal-title":"Head Face Med"},{"key":"1390_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2010.10.007","author":"FP Koch","year":"2011","unstructured":"Koch FP, Merkel C, Al-Nawas B, Smeets R, Ziebart T, Walter C, Wagner W (2011) Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner\u2013a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2. J Craniomaxillof Surg. https:\/\/doi.org\/10.1016\/j.jcms.2010.10.007","journal-title":"J Craniomaxillof Surg"},{"key":"1390_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.10.025","author":"S Ishtiaq","year":"2015","unstructured":"Ishtiaq S, Edwards S, Sankaralingam A, Evans BA, Elford C, Frost ML, Fogelman I, Hampson G (2015) The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. Cytokine. https:\/\/doi.org\/10.1016\/j.cyto.2014.10.025","journal-title":"Cytokine"},{"key":"1390_CR57","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070701","author":"G Duque","year":"2007","unstructured":"Duque G, Rivas D (2007) Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells. J Bone Min Res. https:\/\/doi.org\/10.1359\/jbmr.070701","journal-title":"J Bone Min Res"},{"key":"1390_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-008-0409-y","author":"HK Kim","year":"2009","unstructured":"Kim HK, Kim JH, Abbas AA, Yoon TR (2009) Alendronate enhances osteogenic differentiation of bone marrow stromal cells: a preliminary study. Clin Orthop Relat Res. https:\/\/doi.org\/10.1007\/s11999-008-0409-y","journal-title":"Clin Orthop Relat Res"},{"key":"1390_CR59","first-page":"12150","volume":"12","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhu C, Xia R, Shang X (2019) Alendronate stimulates osteoblast differentiation through PKA-STAT3 and STAT1 in an osteoporosis rat model. Int J Clin Exp Med 12:12150\u201312157","journal-title":"Int J Clin Exp Med"},{"key":"1390_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2003.11.024","author":"G Im","year":"2004","unstructured":"Im G, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS (2004) Osteoblast proliferation and maturation by bisphosphonates. Biomaterials. https:\/\/doi.org\/10.1016\/j.biomaterials.2003.11.024","journal-title":"Biomaterials"},{"key":"1390_CR61","doi-asserted-by":"publisher","DOI":"10.1177\/147323000903700216","author":"Y Xiong","year":"2009","unstructured":"Xiong Y, Yang HJ, Feng J, Shi ZL, Wu LD (2009) Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells. J Int Med Res. https:\/\/doi.org\/10.1177\/147323000903700216","journal-title":"J Int Med Res"},{"key":"1390_CR62","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5381","author":"X Ma","year":"2018","unstructured":"Ma X, Xu Z, Ding S, Yi G, Wang Q (2018) Alendronate promotes osteoblast differentiation and bone formation in ovariectomy-induced osteoporosis through interferon-\u03b2\/signal transducer and activator of transcription 1 pathway. Exp Therap Med. https:\/\/doi.org\/10.3892\/etm.2017.5381","journal-title":"Exp Therap Med"},{"key":"1390_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2014.12.008","author":"FJ Manzano-Moreno","year":"2015","unstructured":"Manzano-Moreno FJ, Ramos-Torrecillas J, De Luna-Bertos E, Ruiz C, Garc\u00eda-Mart\u00ednez O (2015) High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis. J Craniomaxillofac Surg. https:\/\/doi.org\/10.1016\/j.jcms.2014.12.008","journal-title":"J Craniomaxillofac Surg"},{"key":"1390_CR64","doi-asserted-by":"publisher","DOI":"10.1080\/030097498441155","author":"N Giuliani","year":"1998","unstructured":"Giuliani N, Pedrazzoni M, Passeri G, Girasole G (1998) Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand J Rheumatol. https:\/\/doi.org\/10.1080\/030097498441155","journal-title":"Scand J Rheumatol"},{"key":"1390_CR65","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.11.2050","author":"I Mathov","year":"2001","unstructured":"Mathov I, Plotkin LI, Sgarlata CL, Leoni J, Bellido T (2001) Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. J Bone Miner Res. https:\/\/doi.org\/10.1359\/jbmr.2001.16.11.2050","journal-title":"J Bone Miner Res"},{"key":"1390_CR66","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1679","author":"PS Mackie","year":"2001","unstructured":"Mackie PS, Fisher JL, Zhou H, Choong PF (2001) Bisphosphonates regulate cell growth and gene expression in the UMR 106\u201301 clonal rat osteosarcoma cell line. Br J Cancer. https:\/\/doi.org\/10.1054\/bjoc.2000.1679","journal-title":"Br J Cancer"},{"key":"1390_CR67","doi-asserted-by":"publisher","DOI":"10.4103\/2221-1691.233007","author":"AA Raudhah","year":"2018","unstructured":"Raudhah AA, Hermizi H, Hasmah A (2018) Combination treatment of bisphosphonate (pamidronate) and Quercus infectoria semi- purified fraction promotes proliferation and differentiation of osteoblast cell via expression of Osterix and Runx2 marker. Asian Pac J Trop Biomed. https:\/\/doi.org\/10.4103\/2221-1691.233007","journal-title":"Asian Pac J Trop Biomed"},{"issue":"6","key":"1390_CR68","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3390\/ijms20061467","volume":"20","author":"HJ Kim","year":"2019","unstructured":"Kim HJ, Kim HJ, Choi Y, Bae MK, Hwang DS, Shin SH, Lee JY (2019) Zoledronate enhances osteocyte-mediated osteoclast differentiation by IL-6\/RANKL axis. Int J Mol Sci 20(6):1467. https:\/\/doi.org\/10.3390\/ijms20061467","journal-title":"Int J Mol Sci"},{"key":"1390_CR69","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6839","author":"J Chen","year":"2017","unstructured":"Chen J, Lan Y, He Y, He C, Xu F, Zhang Y, Zhao Y, Liu Y (2017) 99Tc-MDP-induced human osteoblast proliferation, differentiation and expression of osteoprotegerin. Molecular Med Rep. https:\/\/doi.org\/10.3892\/mmr.2017.6839","journal-title":"Molecular Med Rep"},{"key":"1390_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<2201::aid-art374>3.0.co;2-e","author":"JC Frith","year":"2001","unstructured":"Frith JC, Monkkonen J, Auriola S, Monkkonen H, Rogers MJ (2001) The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum. https:\/\/doi.org\/10.1002\/1529-0131(200109)44:9%3c2201::aid-art374%3e3.0.co;2-e","journal-title":"Arthritis Rheum"},{"key":"1390_CR71","first-page":"711","volume":"4","author":"AA Reszka","year":"2004","unstructured":"Reszka AA, Rodan GA (2004) Nitrogen-containing bisphosphonate mechanism of action. Mini Rev Med Chem 4:711\u2013719","journal-title":"Mini Rev Med Chem"},{"key":"1390_CR72","first-page":"27","volume":"3","author":"TJ Polascik","year":"2009","unstructured":"Polascik TJ (2009) Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases. Drug Des Devel Ther 3:27\u201340","journal-title":"Drug Des Devel Ther"},{"key":"1390_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2022.12.010","author":"DL van Broekhoven","year":"2023","unstructured":"van Broekhoven DL, Dootjes LW, van der Veldt A, Zillikens C, van Oldenrijk J (2023) Effect of bisphosphonates on skeletal related events in long bone metastases of renal cell carcinoma: a systematic review. Clin Genitourin Cancer. https:\/\/doi.org\/10.1016\/j.clgc.2022.12.010","journal-title":"Clin Genitourin Cancer"},{"key":"1390_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.019","author":"R Coleman","year":"2020","unstructured":"Coleman R, Hadji P, Body JJ, Santini D, Chow E, Terpos E, Oudard S, Bruland \u00d8, Flamen P, Kurth A, Van Poznak C, Aapro M, Jordan K (2020) ESMO guidelines committee. Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2020.07.019","journal-title":"Ann Oncol"},{"key":"1390_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2405","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, S\u00e1ndor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J (2015) International task force on osteonecrosis of the jaw diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.2405","journal-title":"J Bone Miner Res."},{"key":"1390_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116722","author":"R Coropciuc","year":"2023","unstructured":"Coropciuc R, Coopman R, Garip M, Gielen E, Politis C, Van den Wyngaert T, Beuselinck B (2023) Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - A retrospective study of 240 patients. Bone. https:\/\/doi.org\/10.1016\/j.bone.2023.116722","journal-title":"Bone"},{"key":"1390_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06275-w","author":"S Cassia Tornier","year":"2021","unstructured":"Cassia Tornier S, Macedo FJ, Sassi LM, Schussel JL (2021) Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-021-06275-w","journal-title":"Support Care Cancer"},{"key":"1390_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2023.105875","author":"H Hadad","year":"2024","unstructured":"Hadad H, Matheus HR, Pai SI, Souza FA, Guastaldi FPS (2024) Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes. Arch Oral Biol. https:\/\/doi.org\/10.1016\/j.archoralbio.2023.105875","journal-title":"Arch Oral Biol"},{"issue":"6","key":"1390_CR79","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00774-016-0806-3","volume":"35","author":"M Shiraki","year":"2017","unstructured":"Shiraki M, Tanaka S, Suzuki H, Ueda S, Nakamura T (2017) Safety, pharmacokinetics, and changes in bone metabolism associated with zoledronic acid treatment in Japanese patients with primary osteoporosis. J Bone Miner Metab 35(6):675\u2013684. https:\/\/doi.org\/10.1007\/s00774-016-0806-3","journal-title":"J Bone Miner Metab"},{"key":"1390_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-009-0710-7","author":"MA Scheper","year":"2009","unstructured":"Scheper MA, Badros A, Salama AR, Warburton G, Cullen KJ, Weikel DS, Meiller TF (2009) A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-009-0710-7","journal-title":"Support Care Cancer"},{"key":"1390_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136651","author":"M Ponzetti","year":"2021","unstructured":"Ponzetti M, Rucci N (2021) Osteoblast differentiation and signaling: established concepts and emerging topics. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22136651","journal-title":"Int J Mol Sci"},{"key":"1390_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2014.05.003","author":"M Capulli","year":"2014","unstructured":"Capulli M, Paone R, Rucci N (2014) Osteoblast and osteocyte: games without frontiers. Arch Biochem Biophys. https:\/\/doi.org\/10.1016\/j.abb.2014.05.003","journal-title":"Arch Biochem Biophys"},{"key":"1390_CR83","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/421746","author":"R Florencio-Silva","year":"2015","unstructured":"Florencio-Silva R, Sasso GR, Sasso-Cerri E, Sim\u00f5es MJ, Cerri PS (2015) Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/421746","journal-title":"Biomed Res Int"},{"key":"1390_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2016.03.028","author":"FJ Manzano-Moreno","year":"2016","unstructured":"Manzano-Moreno FJ, Ramos-Torrecillas J, De Luna-Bertos E, Reyes-Botella C, Garc\u00eda-Mart\u00ednez O, Ruiz C (2016) Effect of clodronate on antigenic profile, growth, and differentiation of osteoblast-like Cells. J Oral Maxillofac Surg. https:\/\/doi.org\/10.1016\/j.joms.2016.03.028","journal-title":"J Oral Maxillofac Surg"},{"key":"1390_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-014-0074-4","author":"C Seeliger","year":"2015","unstructured":"Seeliger C, Schyschka L, Kronbach Z, Wottge A, van Griensven M, Wildemann B, Vester H (2015) Signaling pathway STAT1 is strongly activated by IFN-\u03b2 in the pathogenesis of osteoporosis. Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-014-0074-4","journal-title":"Eur J Med Res"},{"key":"1390_CR86","doi-asserted-by":"publisher","DOI":"10.1111\/iej.13206","author":"RABD Silva","year":"2020","unstructured":"Silva RABD, Sousa-Pereira AP, Lucisano MP, Romualdo PC, Paula-Silva FWGD, Consolaro A, Silva LAB, Nelson-Filho P (2020) Alendronate inhibits osteocyte apoptosis and inflammation via IL-6, inhibiting bone resorption in periapical lesions of ovariectomized rats. Int Endod J. https:\/\/doi.org\/10.1111\/iej.13206","journal-title":"Int Endod J"},{"key":"1390_CR87","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.003913","author":"L Lin","year":"2018","unstructured":"Lin L, Liang L, Yang X, Sun H, Li Y, Pei D, Zheng H (2018) The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.RA118.003913","journal-title":"J Biol Chem"},{"key":"1390_CR88","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080243","author":"N Samee","year":"2008","unstructured":"Samee N, Geoffroy V, Marty C, Schiltz C, Vieux-Rochas M, Levi G, de Vernejoul MC (2008) Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling. Am J Pathol. https:\/\/doi.org\/10.2353\/ajpath.2008.080243","journal-title":"Am J Pathol"},{"key":"1390_CR89","doi-asserted-by":"publisher","DOI":"10.1177\/15353702211011052","author":"YT Cheng","year":"2021","unstructured":"Cheng YT, Liao J, Zhou Q, Huo H, Zellmer L, Tang ZL, Ma H, Hong W, Liao DJ (2021) Zoledronic acid modulates osteoclast apoptosis through activation of the NF-\u03baB signaling pathway in ovariectomized rats. Exp Biol Med. https:\/\/doi.org\/10.1177\/15353702211011052","journal-title":"Exp Biol Med"},{"key":"1390_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290105","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu H (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. https:\/\/doi.org\/10.1038\/sj.cr.7290105","journal-title":"Cell Res"},{"key":"1390_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071694","author":"T Komori","year":"2019","unstructured":"Komori T (2019) Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20071694","journal-title":"Int J Mol Sci"},{"key":"1390_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.23265","author":"JM Morgan","year":"2011","unstructured":"Morgan JM, Wong A, Yellowley CE, Genetos DC (2011) Regulation of tenascin expression in bone. J Cel Biochem. https:\/\/doi.org\/10.1002\/jcb.23265","journal-title":"J Cel Biochem"},{"key":"1390_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3616","author":"TD Rachner","year":"2014","unstructured":"Rachner TD, G\u00f6bel A, Thiele S, Rauner M, Benad-Mehner P, Hadji P, Bauer T, Muders MH, Baretton GB, Jakob F, Ebert R, Bornh\u00e4user M, Schem C, Hofbauer LC (2014) Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. BCR. https:\/\/doi.org\/10.1186\/bcr3616","journal-title":"BCR"},{"key":"1390_CR94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-145169","author":"JJ Pinzone","year":"2009","unstructured":"Pinzone JJ, Hall BM, Thudi NK, Vonau M, Qiang YW, Rosol TJ, Shaughnessy JD (2009) The role of dickkopf-1 in bone development, homeostasis, and disease. Blood. https:\/\/doi.org\/10.1182\/blood-2008-03-145169","journal-title":"Blood"},{"key":"1390_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-010-0477-8","author":"FP Koch","year":"2012","unstructured":"Koch FP, Merkel C, Ziebart T, Smeets R, Walter C, Al-Nawas B (2012) Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Clin Oral Investig. https:\/\/doi.org\/10.1007\/s00784-010-0477-8","journal-title":"Clin Oral Investig"},{"key":"1390_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/s1357-2725(03)00107-9","author":"EJ Mackie","year":"2003","unstructured":"Mackie EJ (2003) Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol. https:\/\/doi.org\/10.1016\/s1357-2725(03)00107-9","journal-title":"Int J Biochem Cell Biol"},{"key":"1390_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81569-x","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. https:\/\/doi.org\/10.1016\/s0092-8674(00)81569-x","journal-title":"Cell"},{"key":"1390_CR98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3540","author":"H Hsu","year":"1999","unstructured":"Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.96.7.3540","journal-title":"Proc Natl Acad Sci USA"},{"key":"1390_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/s8756-3282(99)00210-0","author":"N Udagawa","year":"1999","unstructured":"Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T (1999) Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone. https:\/\/doi.org\/10.1016\/s8756-3282(99)00210-0","journal-title":"Bone"},{"key":"1390_CR100","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2001.16.9.1593","author":"K Kaji","year":"2001","unstructured":"Kaji K, Katogi R, Azuma Y, Naito A, Inoue JI, Kudo A (2001) Tumor necrosis factor alpha-induced osteoclastogenesis requires tumor necrosis factor receptor-associated factor 6. J Bone Miner Res. https:\/\/doi.org\/10.1359\/jbmr.2001.16.9.1593","journal-title":"J Bone Miner Res"},{"key":"1390_CR101","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23394","author":"S Wei","year":"2005","unstructured":"Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL (2005) IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI23394","journal-title":"J Clin Invest"},{"key":"1390_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.04.058","author":"A Nakao","year":"2007","unstructured":"Nakao A, Fukushima H, Kajiya H, Ozeki S, Okabe K (2007) RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2007.04.058","journal-title":"Biochem Biophys Res Commun"},{"key":"1390_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.03.018","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys. https:\/\/doi.org\/10.1016\/j.abb.2008.03.018","journal-title":"Arch Biochem Biophys"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-025-01390-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01390-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:20:56Z","timestamp":1766755256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-025-01390-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1007\/s00223-025-01390-w","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Henrique Hadad, La\u00eds Kawamata de Jesus, Ma\u00edsa Pereira da Silva, Maria Eduarda de Freitas Santana Oliveira, Fernando Pozzi Semeghini Guastaldi, Ola Nilsson, Roberta Okamoto, and Francisley \u00c1vila Souza have declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"86"}}